Personalized diet- and pharmacotherapy in morbid obesity and metabolic syndrome: A clinical case study
Meditsinskiy sovet = Medical Council · 01.07.2026 · (8) · 182-197
DOI: 10.21518/ms2026-195 ↗Kurz gefasst
Fachartikel in der Zeitschrift Meditsinskiy sovet = Medical Council, online erschienen am 01.07.2026. Verfasst von V. B. Grinevich und 8 weiteren Autor:innen. Die Arbeit nennt 32 Literaturangaben.
Abstract (Originalsprache)
The relevance of this observation is due to the growing problem of morbid obesity and metabolic syndrome, which pose a serious threat to public health worldwide. The case demonstrates the difficulty of managing patients with severe obesity and polymorbidity. The clinical picture of a 60-year-old patient was characterized by morbid obesity (BMI 55.6 kg/m2); metabolic syndrome with type 2 diabetes mellitus, stage III hypertension, dyslipidemia, and fatty hepatosis; cardiovascular disorders with atrial fibrillation, myocardial hypertrophy, pulmonary hypertension; concomitant pathologies: osteoarthritis, chronic pancreatitis, gynecological diseases. The interventions performed included a comprehensive diagnosis of the condition with the involvement of doctors of various specialties, personalized diet therapy and physical therapy, as well as drug therapy with the inclusion of dietary fiber preparations, antihypertensive, hypoglycemic, etc. The outcome of the treatment showed positive dynamics in the form of stabilization of blood pressure, weight loss and improvement of the patient’s general condition. The main conclusions from the presented observation are as follows: the need for a multidisciplinary approach to the treatment of morbid obesity, the importance of personalized diet therapy, the importance of a combination of drug and non-drug treatment, the role of dietary fiber preparation in integrated weight management, the need for long-term patient support to achieve sustainable results. The demonstrated case highlights the complexity of managing patients with morbid obesity and metabolic syndrome, and also demonstrates the effectiveness of an integrated approach while observing all components of diagnosis, treatment, and prevention.
Zitieren
APA
Grinevich, V. B., Kravchuk, Y. A., Salikova, S. P., Zakrevskii, V. V., Seliverstov, P. V., Pronina, E. V., Tenitskiy, P. V., Morozov, N. P., & Vorobyova, V. A. (2026). Personalized diet- and pharmacotherapy in morbid obesity and metabolic syndrome: A clinical case study. Meditsinskiy sovet = Medical Council, 182-197. https://doi.org/10.21518/ms2026-195
Vancouver
Grinevich VB, Kravchuk YA, Salikova SP, Zakrevskii VV, Seliverstov PV, Pronina EV, et al. Personalized diet- and pharmacotherapy in morbid obesity and metabolic syndrome: A clinical case study. Meditsinskiy sovet = Medical Council. 2026:182-197. doi:10.21518/ms2026-195
BibTeX
@article{Grinevich2026,
author = {Grinevich, V. B. and Kravchuk, Yu. A. and Salikova, S. P. and Zakrevskii, V. V. and Seliverstov, P. V. and Pronina, E. V. and Tenitskiy, P. V. and Morozov, N. P. and Vorobyova, V. A.},
title = {Personalized diet- and pharmacotherapy in morbid obesity and metabolic syndrome: A clinical case study},
journal = {Meditsinskiy sovet = Medical Council},
year = {2026},
number = {8},
pages = {182--197},
doi = {10.21518/ms2026-195}
}
EUVIMED